4894
J.T. Feutrill et al. / Tetrahedron 64 (2008) 4880e4895
4.21. Crocacin A (1)
found 791.4088. Further elution with 30% EtOAc/petrol then
afforded the enamide isomer 66 (7.2 mg, 28%). [a]1D8 þ46.0
(c 0.19, CH2Cl2); IR nmax (thin film) 2955, 2929, 1732, 1681,
1596, 1251, 1178, 1091 cmꢀ1; 1H NMR (400 MHz) d 0.02 (s,
9H), 0.04 (s, 9H), 0.84 (d, J¼6.8 Hz, 3H), 0.98e1.04 (m,
4H), 1.19 (d, J¼7.2 Hz, 3H), 1.54 (m, 1H), 2.20 (s, 3H), 2.57
(m, 1H), 3.06 (d, J¼6.8 Hz, 1H), 3.19 (dd, J¼10.0, 2.0 Hz,
2H), 3.32 (s, 3H), 3.54 (s, 3H), 3.96 (d, J¼5.6 Hz, 2H), 4.07
(br d, J¼8.0 Hz, 1H), 4.20e4.28 (m, 4H), 5.90 (dt, J¼14.4,
9.6 Hz, 1H), 5.95e6.20 (m, 4H), 6.07 (d, J¼10.0 Hz, 1H),
6.07 (d, J¼10.0 Hz, 1H), 6.15 (dd, J¼14.4, 7.6 Hz, 1H), 6.44
(d, J¼0.8 Hz, 1H), 6.56 (d, J¼16.0 Hz, 1H), 7.22 (m, 1H),
7.29 (m, 2H), 7.39 (m, 2H); 13C NMR (100 MHz) d ꢀ1.56,
ꢀ1.52, 9.8, 14.7, 17.3, 17.5, 18.6, 29.7, 40.2, 41.5, 42.6, 56.4,
61.4, 63.9, 65.6, 81.0, 86.3, 120.8, 123.8, 126.4, 126.9, 127.5,
127.9, 128.5, 128.9, 129.1, 132.0, 134.2, 136.7, 138.7, 152.5,
153.8, 167.7, 169.8, 170.4; HRMS (ESI) calculated for
C41H64N2NaO8Si2 [MþNa]þ 791.4093, found 791.4084.
A solution of TBAF (5.4 mg, 0.017 mmol) in THF (0.8 mL)
at 0 ꢁC was added to the protected natural product 62 (5.8 mg,
0.009 mmol) and the resultant solution allowed to stir at 0 ꢁC
for 30 min. EtOAc and pH 7 buffer were then added and the
phases separated. The aqueous phase was extracted twice
further with EtOAc and the combined organic fractions washed
with brine, dried (Na2SO4), filtered and evaporated to afford the
crude natural product. Column chromatography on NEt3 deac-
tivated silica gel with 40% EtOAc/petrol/1% NEt3 as eluant fol-
lowed by further purification by RP-HPLC (10% H2O/MeOH)
afforded crocacin A (1) (2.6 mg, 57%). [a]1D9 þ126.8 (c 0.077,
MeOH); lit.3 [a]D22 þ109.6 (c 1.0, MeOH); IR nmax (thin film)
3359, 2955, 2361, 2341, 1732, 1675, 1251, 1175 cmꢀ1; H
1
NMR (400 MHz, acetone-d6) d 0.86 (d, J¼7.2 Hz, 3H), 1.18
(d, J¼6.8 Hz, 3H), 1.56 (m, 1H), 2.26 (s, 3H), 2.61 (m, 1H),
3.18 (dd, J¼9.6, 2.0 Hz, 1H), 3.29 (s, 3H), 3.31 (dd, J¼8.6,
8.6 Hz, 2H), 3.52 (s, 3H), 3.68 (s, 3H), 4.08 (m, 3H), 4.77 (dt,
J¼8.4, 8.4 Hz, 1H), 5.81 (br s, 1H), 5.95 (d, J¼11.2 Hz, 1H),
6.05 (dt, J¼11.2, 8.8 Hz, 1H), 6.14 (dd, J¼15.4, 8.0 Hz, 1H),
6.19 (d, J¼15.6 Hz, 1H), 6.24 (dd, J¼16.0, 7.2 Hz, 1H), 6.58
(d, J¼16.0 Hz, 1H), 6.82 (dd, J¼10.6, 8.4 Hz, 1H), 7.21 (dd,
J¼7.6, 7.2 Hz, 1H), 7.30 (dd, J¼8.0, 7.6 Hz, 2H), 7.46 (d,
J¼7.2 Hz, 2H), 7.98 (br m, 1H), 10.05 (br d, J¼10.4 Hz, 1H);
13C NMR (100 MHz, acetone-d6) d 10.1, 13.6, 19.2, 26.2,
40.8, 41.6, 43.4, 52.3, 56.4, 61.4, 81.7, 87.0, 104.3, 120.9,
121.7, 125.8, 127.2, 128.2, 129.3, 130.3, 132.5, 135.1, 137.7,
137.8, 143.4, 149.8, 164.4, 168.9, 170.6; HRMS (ESI) calcu-
lated for [MþNa]þ 791.4093, found 791.4088.
4.23. Crocacin B (2)
A solution of TBAF (6.6 mg, 0.02 mmol) in THF (1.5 mL)
cooled to 0 ꢁC was added to the teoc ester 65 (5.4 mg,
0.007 mmol). The reaction was allowed to stir for 2.5 h at
0 ꢁC, then ethylacetate and pH 7 buffer were added and the
phases separated. The aqueous phase was extracted twice fur-
ther with ethylacetate and the combined organic fractions
washed with brine, dried (Na2SO4), filtered and evaporated to
yield crocacin B (2) (2.5 mg, 68%). Attempted purification of
this material (RP-HPLC) resulted only in extensive decomposi-
tion so the data reported is for crude material. [a]1D8 þ75.0 (c
0.1, MeOH); lit.3 [a]D22 þ99.0 (c 0.5, MeOH); IR nmax (thin
4.22. Enamide 65
1
film) 3322, 2928, 2852, 1732, 1622, 1402, 1090 cmꢀ1; H
To a solution of the crude acid 61 and tmse protected glycine
6458 (11.7 mg, 0.07 mmol) in CH2Cl2 (0.25 mL) at 0 ꢁC were
added DCC (13.8 mg, 0.066 mmol) and a solution of DMAP
(0.04 mg, 0.3 mmol) in CH2Cl2 (50 mL). The reaction was
stirred for 2.5 h at 0 ꢁC, then petroleum spirit added and the re-
action filtered through Celite. Concentration then afforded the
crude material, which was purified by flash chromatography
(20% EtOAc/petrol) to afford the enamide 65 as a colourless
oil (5.4 mg, 21%). [a]1D6 þ43.3 (c 0.27, CH2Cl2); IR nmax
(thin film) 3359, 2955, 2361, 2341, 1732, 1675, 1251,
NMR (400 MHz, acetone-d6) d 0.86 (d, J¼6.8 Hz, 3H), 1.17
(d, J¼6.8 Hz, 3H), 1.57 (m, 1H), 2.26 (d, J¼0.8 Hz, 3H),
2.61 (m, 1H), 3.18 (dd, J¼9.6, 2.4 Hz, 1H), 3.28 (s, 3H), 3.32
(dd, J¼8.4, 8.4 Hz, 2H), 3.51 (s, 3H), 4.00e4.10 (m, 3H),
4.77 (dt, J¼8.4, 8.4 Hz, 1H), 5.86 (s, 1H), 5.97 (d,
J¼11.6 Hz, 1H), 6.05 (dt, J¼11.6, 8.4 Hz, 1H), 6.10 (dd,
J¼15.6, 8.4 Hz, 1H), 6.19 (d, J¼16.0 Hz, 1H), 6.24
(dd, J¼16.0, 7.2 Hz, 1H), 6.58 (d, J¼16.0 Hz, 1H), 6.82 (dd,
J¼10.8, 8.8 Hz, 1H), 7.22 (d, J¼7.6, 7.2 Hz, 1H), 7.31
(dd, J¼8.0, 7.4 Hz, 2H), 7.45 (br d, J¼8.4 Hz, 2H), 7.91 (br t,
J¼8.4 Hz), 10.11 (d, J¼10.8 Hz); 13C NMR (100 MHz, ace-
tone-d6) d 10.1, 13.7, 19.1, 26.2, 40.7, 41.4, 43.3, 56.4, 61.4,
81.8, 87.2, 104.3, 121.0, 121.8, 125.8, 127.2, 128.2, 129.3,
130.4, 132.5, 135.2, 137.5, 137.8, 143.2, 149.7, 164.4, 168.8,
170.9; HRMS (ESI) calculated for [MþNa]þ 547.2778, found
547.2773.
1
1175 cmꢀ1; H NMR (400 MHz) d 0.02 (s, 9H), 0.04 (s, 9H),
0.84 (d, J¼6.9 Hz, 3H), 0.96e1.07 (m, 4H), 1.18 (d,
J¼6.8,Hz, 3H), 1.55 (m, 1H), 2.18 (s, 3H), 2.57 (m, 1H), 3.18
(dd, J¼8.4, 3.0 Hz, 1H), 3.24e3.36 (m, 5H), 3.54 (s, 3H),
4.00 (d, J¼5.1 Hz, 2H), 4.08 (br d, J¼5.1 Hz, 1H), 4.20e4.28
(m, 4H), 5.56 (dt, J¼7.8, 7.8 Hz, 1H), 5.74 (d, J¼11.4 Hz,
1H), 5.95 (dt, J¼11.4, 7.2 Hz, 1H), 6.05 (d, J¼7.8 Hz, 1H),
6.10e6.20 (m, 3H), 6.45 (s, 1H), 6.55 (d, J¼16.2 Hz, 1H),
7.22 (m, 1H), 7.31 (m, 2H), 7.39 (d, J¼7.2 Hz); 13C NMR
(100 MHz) d ꢀ1.55, ꢀ1.52, 9.8, 14.7, 17.3, 17.5, 18.7, 29.7,
40.2, 41.2, 42.6, 56.4, 61.4, 63.9, 65.5, 81.0, 86.4, 121.2,
122.4, 124.7, 126.4, 127.4, 127.5, 128.5, 129.2, 131.9, 134.4,
136.7, 138.2, 142.0, 151.7, 153.7, 165.8, 167.9, 170.0; HRMS
(ESI) calculated for C41H64N2NaO8Si2 [MþNa]þ 791.4093,
Acknowledgements
We thank the Australian Research Council for funding. We
are also indebted to Dr. Rolf Jansen (Gesellschaft fur Biotechno-
¨
logische Forschung) for copies of the 1H and 13C NMR spectra
of crocacins AeD (1e4) as well as authentic samples.